弱势群体的癌症研究: MENAT国家呼吁合作和可持续性
Marwan Tolba1, Mac Skelton2,3, Zahi Abdul Sater4,5
1Department of Radiation Oncology, Dalhousie University, and Cape Breton Cancer Center, Sydney, Nova Scotia, Canada.
JCO global oncology
|December 14, 2023
概括
在中东,北非和土耳其 (MENAT) 的弱势群体中进行的癌症研究缺乏. 资金和时间等重大障碍阻碍了进展,需要跨学科的方法来改善护理和结果.
科学领域:
- 在瘤学瘤学.
- 公共卫生 公共卫生
- 健康差异 在健康上的差异
背景情况:
- 在中东,北非和土耳其 (MENAT) 地区,癌症对健康造成重大负担.
- 在 MENAT 国家的冲突加剧了现有的脆弱性,但这些人群中的癌症研究是有限的.
- 了解弱势群体癌症研究的情况,对于制定有针对性的干预措施至关重要.
研究的目的:
- 评估目前的癌症研究现状和潜力,包括MENAT地区的弱势群体.
- 确定在这个人口群体中进行癌症研究的障碍和促进因素.
- 为制定区域癌症研究议程提供信息,重点关注弱势群体.
主要方法:
- 举行了10位作者参与的专家会议.
- 获得了机构审查委员会批准.
- 在22个MENAT国家的500多名癌症从业人员中进行了在线调查.
主要成果:
- 216名癌症从业人员作出回应,其中50%认为易受癌症患者的研究是有意义的.
- 只有21.8%的受访者报告说,他们以前曾经与弱势群体进行过研究,尽管60%的受访者每天都会遇到他们.
- 确定的主要障碍包括缺乏资金 (60%),受保护的时间 (42%) 和研究培训 (35%).
- 战争和冲突被认为是脆弱性的重要来源,与年龄,绝症,心理健康问题,慢性疾病和社会经济贫困一起.
结论:
- 需要做出大量努力,以加强MENAT地区弱势群体的癌症研究.
- 需要一个跨学科的研究议程,解决独特的区域脆弱性,平衡社会行为和临床研究.
- 与国际合作伙伴的合作对于建立一个强大的研究框架和提高护理质量至关重要.
相关概念视频
01:21Cancer Survival Analysis
355
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
355
02:43Mouse Models of Cancer Study
5.6K
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
5.6K
02:57Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K